Skip to content

Multidimensional Assessment of Pathophysiological Mechanisms of Endometriosis-Associated Chronic Pain within the StEPP-UPP Consortium – a Non-Interventional Study (StEPP-UPP NIT-1)

Multidimensional Assessment of Pathophysiological Mechanisms of Endometriosis-Associated Chronic Pain within the StEPP-UPP Consortium – a Non-Interventional Study (StEPP-UPP NIT-1) - StEPP-UPP-NIT1

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037319
Enrollment
150
Registered
2025-07-09
Start date
2025-08-27
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N80

Interventions

Group 1: Women aged 18 to 50 years with suspected or confirmed endometriosis (ICD-10 N80.x), scheduled for endometriosis-related or elective abdominal/pelvic surgery, who will be observed within the S

Sponsors

Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie des Universitätsklinikums Münster
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Confirmed or suspected diagnosis of endometriosis according to ICD-10 code N80.x (including, for example, N80.0–N80.9) Planned surgical procedure, either: a. for the diagnosis or treatment of endometriosis (e.g., endometriosis excision), or b. an elective abdominal or pelvic surgery in patients with confirmed endometriosis Capacity to consent and provision of written informed consent Sufficient proficiency in German to understand and complete study questionnaires and digital assessment tools

Exclusion criteria

Exclusion criteria: Age under 18 or over 50 years; pregnancy or breastfeeding; lack of capacity to consent; cognitive impairment preventing completion of study questionnaires; insufficient German language skills to complete assessment tools; missing or refused written informed consent; preoperative blood draw is refused by the patient or is not possible.

Design outcomes

Primary

MeasureTime frame
Pain intensity (Numeric Rating Scale, NRS); pain-related functional impairment (Brief Pain Inventory, BPI); endometriosis-specific quality of life (Endometriosis Health Profile, EHP-30); pain characteristics (EPQ-S – Standard EPHect Questionnaire).

Secondary

MeasureTime frame
Menstrual and reproductive history (EPQ-S); medical and surgical history (EPQ-S); sociodemographic data (EPQ-S); pain sensitivity (Pain Sensitivity Questionnaire, PSQ-Minor); pain-related disability (Pain Disability Index, PDI); central sensitization (Central Sensitization Inventory, CSI); neuropathic pain features (DN4, NPSI); postoperative pain symptoms (modified Core Outcome Set for Endometriosis); psychological distress (Depression Anxiety Stress Scales, DASS-42); fatigue (Fatigue Scale for Motor and Cognitive Functions, FSMC); analgesic intake (manual documentation); opioid-related side effects (Opioid-Related Symptom Distress Scale, ORSDS); sensory function (bedside Quantitative Sensory Testing, QST); molecular biomarkers from blood, stool, and tissue (targeted and untargeted proteomics).

Countries

Germany

Contacts

Public ContactEsther Pogatzki-Zahn

Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie des Universitätsklinikums Münster

pogatzki@anit.uni-muenster.de02518347261

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026